Retail investors have significant control over Vaxart, giving them influence on management decisions. Institutions own 11%, while hedge funds have no substantial investment. The general public holds 59% ownership, indicating potential sway in key policy decisions. Private equity firms own 6.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing